我国基层药品不良反应监测机构建设和发展的探讨  

Study on Construction and Development of Primary Adverse Drug Reaction Monitoring System in China

作　　者：谢金洲[1] 周勇[1] 黄传海[1] 田月洁[1] 陈易新[2] 

机构地区：[1]山东省药品不良反应监测中心,山东济南250013 [2]国家食品药品监督管理局药品评价中心,北京100045

出　　处：《中国药物警戒》2009年第3期152-155,共4页Chinese Journal of Pharmacovigilance

摘　　要：目的研究我国省级以下药品不良反应监测机构建设和发展现状,为健全我国基层监测体系提供科学依据。方法采用理论联系实际、调研和实践相结合的方法。结果全国基层药品不良反应监测机构建设尚不完善,诸多问题亟需解决。结论建立、健全各级基层药品不良反应监测体系是保障我国药品不良反应监测事业可持续发展的前提和基础。Objective Through study on construction and development of the below the provincial level adverse drug reaction（ADR） monitoring organization system, it provides a scientific evidence to perfect primary monitoring system. Methods A combined method of literature retrieval, surveys, onsite investigation and practice are used in the study. Results It needs urgent solutions that national primary ADR Monitoring system is imperfect and impact sustainable development. Conclusion It is the basis for implementation monitoring sustainable development through to establish and improve primary ADR monitoring System.

关 键 词：药品不良反应 监测 组织 

分 类 号：R954[医药卫生—药学] R994.11